Navigation Links
Hissey Kientz, LLP Warns Duragesic Patch Users about Potential Health Risks of Fentanyl Overdose
Date:8/19/2009

The law firm of Hissey Kientz, LLP is urging the manufacturers of the fentanyl or Duragesic pain patches to address recurring problems with their products that could lead to a potentially fatal overdose. Because of its high potency, patients who receive too much of the medication in the pain patch are at an increased risk of a fentanyl overdose. Watson Pharmaceuticals recalled one lot of its fentanyl patches on August 7, 2009. The patches were recalled because a number of them have been leaking fentanyl gel.

(Vocus) August 18, 2009 -- The law firm of Hissey Kientz, LLP is urging the manufacturers of the fentanyl or Duragesic pain patches to address recurring problems with their products that could lead to a potentially fatal overdose. Fentanyl or Duragesic patches have been recalled on at least six occasions since 2004 because of manufacturing defects.

On August 7, 2009, Watson Pharmaceuticals recalled Lot Number 145287A of its 100 mcg/hr fentanyl patches. The recalled patches were shipped between April 2 and May 20, 2009 and expire in February 2011.

Watson’s patches use the “reservoir design” in which a reservoir of fentanyl gel is used to deliver pain medication. The patches were recalled because a number of them have been leaking fentanyl gel.

“This isn’t the first time reservoir design patches have been recalled due to leakage. How many more recalls must there be before manufacturers abandon this dangerous design?” asked Kathleen McGinn, an attorney with Hissey Kientz.

The Duragesic pain patch—marketed generically as fentanyl—was approved by the Food and Drug Administration in 1990 for the treatment of chronic pain. Because the patch is approximately 80 times more powerful than morphine, Duragesic and fentanyl are only prescribed to patients who have developed a high tolerance to pain medications.

Because of its high potency, patients who receive too much of the medication in the pain patch are at an increased risk of a fentanyl overdose. Direct exposure to fentanyl gel can cause too much medication to enter the patient’s bloodstream, which may be fatal. The use of heating blankets can also cause the patch to release medication too quickly, increasing the risk of an overdose.

In May 2009, rock musician Jay Bennett—formerly of the group Wilco—was found dead of what a coroner’s examination later ruled was an overdose caused by the fentanyl patch. The FDA issued a warning about the dangers of the Duragesic and fentanyl patches in July 2005 after it received reports of at least 120 deaths related to their use.

Dozens of lawsuits have been filed against the manufacturers of the Duragesic or fentanyl patches. Many allege that an individual was killed by a defective pain patch. The manufacturers of fentanyl patches have lost all of the cases that have gone to trial so far (Nos. 04-CA-13H-1C-K, 05-8116, 2005-11685). The largest verdict to date was $16.5 million dollars to the family of a Chicago woman who died while wearing a reservoir-style fentanyl patch (No. 04-L-5351).

“We are very interested in speaking to anyone who believes a loved one died because of any fentanyl patch, even if the patch wasn’t in a recalled lot,” said McGinn.

Lawsuits are currently pending across the country against every major manufacturer of fentanyl patches, including Watson. No Watson lawsuit has yet gone to trial as of the present date.

About Hissey Kientz, LLP
Hissey Kientz, LLP is currently accepting cases involving individuals who may have been injured as a result of a fentanyl or Duragesic overdose. Hissey Kientz, LLP also represents those who contracted mesothelioma or lung cancer as a result of asbestos exposure, and those injured by Fleet Phospho-soda, Digitek, Zicam, the Composix Kugel mesh patch, gadolinium MRI contrast dyes or other defective drugs and devices. To learn more about the firm and other drug cases, visit Hissey Kientz, LLP (www.hkllp.com) or call toll-free at (866) 275-4454.

###

Read the full story at http://www.prweb.com/releases/2009/08/prweb2762414.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Hissey Kientz Announces the Launch of Herbal Fen Phen Lawyers Website
2. Supreme Court Ruling is a Victory for Consumers Injured by Dangerous Drugs, Says Hissey Kientz, LLP
3. Hissey Kientz, LLP Announces the Launch of Mesothelioma Lawyers Help Web Site
4. Hissey Kientz, LLP Warns Duragesic Patch Users About Potential Health Risks of Fentanyl Overdose
5. Hissey Kientz, LLP Announces the Launch of Digitek Recall Help Web Site
6. Hissey Kientz Concerned That Patients Have Not Been Provided With Crucial Information About Digitek Recall Despite the Dangers of Digoxin Toxicity
7. Retirees health-care benefits at risk, study warns
8. Ohio Law Firm Warns of Birth Control Pill YAZ/Yasmin Side Effects Lawsuits
9. Ex-House Aging Committee Chief of Staff Bob Weiner Warns of Insurance Control Over Health Bill Outcome, Praises House Version, Disappointed by Senate; Weiner and Policy Analyst Jordan Osserman Offer Bills Prognosis
10. Massachusetts Warns: Bisphenol A Toxic
11. Carboxytherapy and Mesotherapy Unproven, Warns The Physicians Coalition for Injectable Safety
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Hissey Kientz, LLP Warns Duragesic Patch Users about Potential Health Risks of Fentanyl Overdose
(Date:12/8/2016)... MA (PRWEB) , ... December 08, 2016 , ... ... Workers Compensation Research Institute (WCRI) officially opened registration today for its 33rd ... Hotel in Boston, MA . , The theme of the conference is “Persistent ...
(Date:12/8/2016)... PLAINS, N.Y., and JENNERSVILLE, Pa. (PRWEB) , ... ... ... to announce that Penn Medicine Southern Chester County, a Property owned by an ... The $23 million, 72,000 square foot Penn Medicine Southern Chester County ambulatory care ...
(Date:12/8/2016)... , ... December 08, 2016 , ... With the increasing ... the “What’s In Your Mouth?” (WIYM) campaign to inform dentists and patients about the ... the dental implant and prosthetic market in the U.S. is projected to reach $6.4 ...
(Date:12/8/2016)... ... 08, 2016 , ... SunView Software aims to redefine IT ... both engaging and easy to use. Coming off the heels of a successful ... its plans to roll out new AI-powered self-service enhancements to help organizations implement ...
(Date:12/8/2016)... ... December 08, 2016 , ... STATEN ... been recognized for adherence to the highest standards of trauma, maternity, cancer and ... the center's president and CEO, Dr. Daniel Messina. , Among the recognitions, the ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)...  A Mederi Therapeutics Inc . anunciou aprovação regulatória, pela CFDA, e ... doença do refluxo gastroesofágico (DRGE). Foto -  http://photos.prnewswire.com/prnh/20161207/446903 ... ... Live Stretta procedure performed and broadcast during the Chinese Congress of Digestive Endoscopy, ... , , ...
(Date:12/8/2016)... CITY , Dec. 8, 2016 ... US patents for improving the accuracy, reproducibility and ... images in long and small bone orthopaedic applications. ... approach to creating personalized orthopaedic restorations based on ... personalized orthopaedic restorations, the company harnesses the world,s ...
(Date:12/8/2016)... 2016  Valeant Pharmaceuticals International, Inc. (NYSE: ... announced positive results from a Phase 3, multicenter ... safety and efficacy of IDP-118 (halobetasol propionate and ... Within the Phase 3 study ... psoriasis, IDP-118 showed statistical significance to vehicle with ...
Breaking Medicine Technology: